NATIONAL HEALTH INVESTORS INC financial data

Symbol
NHI on NYSE
Location
Murfreesboro, TN
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 26 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity 84% % -12%
Return On Equity 9.6% % -11%
Return On Assets 5.2% % -5.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 48,392,384 shares 3.6%
Common Stock, Shares, Outstanding 48,302,944 shares 5.7%
Entity Public Float $2,900,000,000 USD 3.3%
Common Stock, Value, Issued $483,000 USD 5.7%
Weighted Average Number of Shares Outstanding, Basic 46,874,691 shares 6.9%
Weighted Average Number of Shares Outstanding, Diluted 47,051,763 shares 6.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $375,628,000 USD 12%
Revenue from Contract with Customer, Excluding Assessed Tax $80,062,000 USD 47%
General and Administrative Expense $26,868,000 USD 30%
Net Income (Loss) Attributable to Parent $142,177,000 USD 3%
Earnings Per Share, Basic 3.03 USD/shares -3.5%
Earnings Per Share, Diluted 3.02 USD/shares -3.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $19,624,000 USD -19%
Property, Plant and Equipment, Net $2,473,758,000 USD 12%
Operating Lease, Right-of-Use Asset $1,500,000 USD 0%
Assets $2,796,887,000 USD 7%
Liabilities $1,256,983,000 USD 2.3%
Retained Earnings (Accumulated Deficit) $2,747,006,000 USD 5.5%
Stockholders' Equity Attributable to Parent $1,521,543,000 USD 11%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $1,529,709,000 USD 11%
Liabilities and Equity $2,796,887,000 USD 7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $46,478,000 USD 14%
Net Cash Provided by (Used in) Financing Activities $139,766,000 USD
Net Cash Provided by (Used in) Investing Activities $75,469,000 USD -366%
Common Stock, Shares Authorized 100,000,000 shares 0%
Common Stock, Shares, Issued 48,302,944 shares 5.7%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $110,775,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $19,624,000 USD -26%
Interest Paid, Excluding Capitalized Interest, Operating Activities $16,873,000 USD -0.45%
Deferred Tax Assets, Valuation Allowance $277,000 USD -70%
Deferred Tax Assets, Gross $4,726,000 USD 58%
Operating Lease, Liability $1,700,000 USD 0%
Depreciation $77,971,000 USD 12%
Property, Plant and Equipment, Gross $3,295,740,000 USD 12%
Lessee, Operating Lease, Liability, to be Paid, Year Two $100,000 USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One $100,000 USD 0%
Operating Lease, Weighted Average Discount Rate, Percent 0.047 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,100,000 USD -8.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three $100,000 USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $100,000 USD 0%
Deferred Tax Assets, Net of Valuation Allowance $4,449,000 USD 114%
Share-based Payment Arrangement, Expense $5,576,000 USD 33%
Interest Expense $57,368,000 USD -4.2%